Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis-Reference-Cited by-同舟云学术

Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis

Published:2017-12-11 Issue:4 Volume:111 Page:217-224
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Cooke G¹,Kamal I²³,Strengert M²,Hams E⁴⁵,Mawhinney L⁴,Tynan A⁴,O’Reilly C⁴,O’Dwyer D N²³,Kunkel S L⁶,Knaus U G²,Shields D C⁷,Moller D R⁸,Bowie A G⁹,Fallon P G⁴⁵,Hogaboam C M⁶,Armstrong M E⁴,Donnelly S C⁴¹⁰

Affiliation:

1. Department of Applied Sciences, Institute of Technology Tallaght, Tallaght, Dublin 24, Ireland

2. School of Medicine and Medical Science, College of Life Sciences, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland

3. National Pulmonary Fibrosis Referral Centre at St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland

4. School of Medicine, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland

5. National Children’s Research Centre, Our Lady’s Children’s Hospital Crumlin, Dublin 12, Ireland

6. Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA

7. UCD Complex and Adaptive Systems Laboratory, University College Dublin, Belfield, Dublin 4, Ireland

8. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA

9. School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College, Dublin 2, Ireland

10. Department of Clinical Medicine, Trinity Centre for Health Sciences, Tallaght Hospital, Tallaght, Dublin 24, Ireland

Funder

Health Research Board

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/qjmed/article-pdf/111/4/217/24563534/hcx243.pdf

Reference35 articles.

1. Sarcoidosis;Iannuzzi;N Engl J Med,2007

2. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999;Statement on Sarcoidosis;Am J Respir Crit Care Med,1999

3. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study;Pietinalho;Sarcoidosis,1995

4. Etiologies of sarcoidosis;Chen;Clin Rev Allergy Immunol,2015

5. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis;Moller;J Immunol,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung fibrosis in sarcoidosis. Is there a place for antifibrotics?;Frontiers in Pharmacology;2024-08-30

2. Non-lipid genetic predictors of the development of coronary heart disease and myocardial infarction in patients with hypertension;Bulletin of the Russian Military Medical Academy;2024-06-10

3. Sarcoidosis immunopathogenesis – a new concept of maladaptive trained immunity;Trends in Immunology;2024-06

4. The immunopathogenesis of sarcoidosis;Journal of Autoimmunity;2024-05

5. Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis;Journal of Clinical Investigation;2024-01-02